NMR-based Lipoprotein Analysis for Patients With Advanced Hypercholesterolemia Undergoing Chronic Lipoprotein Apheresis or PCSK9-inhibitor Therapy (NAPALI)-Study
Therapeutic Apheresis and Dialysis - United Kingdom
doi 10.1111/1744-9987.12792
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2019
Authors
Publisher
Wiley